Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2. · scientific article · YYNN

Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.

? TBD

scientific article

Ratings
0

Nobody has rated this yet. Be the first!

Lists
0

Instance of

Scholarly article

Author

Subject

Monoclonal antibody

Wikidata